⌘K

Home/Filings/4/0001209191-18-014687

4//SEC Filing

Cohee Gary 4

Accession 0001209191-18-014687

CIK 0001006028other

View on SEC.gov Company Profile

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 7:10 PM ET

Size

5.7 KB

Accession

0001209191-18-014687

Insider Transaction Report

Form 4

Period: 2018-02-26

PURE BIOSCIENCE, INC.PURE

Director

Transactions

Award
Stock Option (Right to Buy)
2018-02-26+100,000→ 100,000 total
Exercise: $0.78Exp: 2023-02-27→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

PURE BIOSCIENCE, INC.

CIK 0001006028

Entity typeother

Related Parties

1

filerCIK 0001453116

Filing Metadata

Form type: 4
Filed: Feb 27, 7:00 PM ET
Accepted: Feb 28, 7:10 PM ET
Size: 5.7 KB

View on SEC.gov